| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |